Parth Adrejiya

Dr. Parth Adrejiya

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2025 in HeartRhythm Case Reports
Verified
Journal Article
Open access
MAMohammad Abubaker
Mohammad Abubaker
Parth AdrejiyaParth Adrejiya
Parth Adrejiya
LBLewam Berhe
Lewam Berhe
SCSrinivasa Chennareddy
Srinivasa Chennareddy
AKAshok Kanugula
Ashok Kanugula

25 March 2026 in The American Journal of Cardiology
Verified
Journal Article
Closed access
Parth AdrejiyaParth Adrejiya
Parth Adrejiya
ABAditi Bhanushali
Aditi Bhanushali
KMKahan Mehta
Kahan Mehta
MAMatthew Amin
Matthew Amin
GVGladys R. R Velarde
Gladys R. R Velarde

29 June 2023 in International Journal Of Community Medicine And Public Health
Verified
Journal Article
Open access
PDF file
Parth AdrejiyaParth Adrejiya
Parth Adrejiya
SBSonia Barve
Sonia Barve
SNSandeep Nanda
Sandeep Nanda
Background: Aedes aegypti and Aedes albopictus are the primary effective vectors for the dengue virus in India. The disease is conveyed through the bite of infected mosquitoes of the Aedes species and is the most quickly expanding vector-borne viral disease globally, putting an increasing number of locations at risk. Methods: We looked at the laboratory surveillance data and reported the percentage of dengue cases that were confirmed in the lab by month, location (urban vs. rural), and individual (age vs. gender) factors. Results: The maximum no. of suspected cases as well as found positive were in the monsoon and post-monsoon period from July to November. The dengue suspected cases were significantly more in the adult age group than in the pediatric age group. More cases were seen in urban areas than the rural areas. Conclusions: Serology confirmed positive dengue cases were maximum in the adult group residing in an urban area in the period of monsoon and post-monsoon period from July to November.

8 September 2025 in Baylor University Medical Center Proceedings
Verified
Journal Article
Closed access
Parth AdrejiyaParth Adrejiya
Parth Adrejiya
EAEnsaf Alhujaily
Ensaf Alhujaily
MAMohammad Abubaker
Mohammad Abubaker
CDChelsae Dorenbush
Chelsae Dorenbush
RKRami Khouzam
Rami Khouzam
Euglycemic diabetic ketoacidosis (EDKA) is a rare but serious complication of type 2 diabetes, traditionally linked to SGLT-2 inhibitors. We report a 59-year-old woman with type 2 diabetes and gastroparesis who discontinued SGLT-2 inhibitors 1 month earlier and developed EDKA shortly after initiating dulaglutide. She presented with nausea, vomiting, abdominal pain, and a modestly elevated glucose level. Laboratory findings confirmed EDKA, and she was successfully treated with intravenous insulin and fluids. Dulaglutide was discontinued, with no recurrence on follow-up. This case underscores the potential for GLP-1 receptor agonists to trigger EDKA in susceptible patients and the need for heightened clinical awareness.

24 March 2021 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
KPKesar Prajapati
Kesar Prajapati
JPJaya Pathak
Jaya Pathak
VSVikranti Sailor
Vikranti Sailor
Parth AdrejiyaParth Adrejiya
Parth Adrejiya
Ellis-van Creveld (EVC) syndrome is a relatively rare chondroectodermal dysplasia considered mainly as a generalised disorder of the maturation of endochondral ossification. Congenital heart disease occurs in approximately half of the patients with EVC syndrome, 60% of which is a common atrium. Common atrium is a rare variety of interatrial communication characterised by absence or virtual absence of the atrial septum. Patients with this syndrome rarely survive to an old age. We report a case of EVC who presented for the first time at 60 years of age, as survival to an advanced age is exceptional in case of EVC.